Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Asset Resilience Ratio

Latest as of June 2025: 6.09%

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A asset resilience ratio. Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has an Asset Resilience Ratio of 6.09% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688212 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥113.00 Million
≈ $16.54 Million USD Cash + Short-term Investments

Total Assets

CN¥1.86 Billion
≈ $271.68 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2021–2024)

Asset resilience ratio of Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A from 2021 to 2024. This chart shows how Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's Asset Resilience Ratio has changed over time. Read Shanghai Aohua Photoelectricity Endoscop (688212) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai Aohua Photoelectricity Endoscop total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥113.00 Million 6.09%
Total Liquid Assets CN¥113.00 Million 6.09%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A maintains only 6.09% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Asset Resilience Ratio by Year (2021–2024)

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A asset resilience ratio by year from 2021 to 2024. The table below shows the annual Asset Resilience Ratio data for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 7.25% CN¥126.81 Million
≈ $18.56 Million
CN¥1.75 Billion
≈ $255.89 Million
-13.66pp
2023-12-31 20.91% CN¥333.60 Million
≈ $48.82 Million
CN¥1.60 Billion
≈ $233.41 Million
-9.45pp
2022-12-31 30.37% CN¥443.40 Million
≈ $64.88 Million
CN¥1.46 Billion
≈ $213.66 Million
+26.96pp
2021-12-31 3.41% CN¥46.03 Million
≈ $6.74 Million
CN¥1.35 Billion
≈ $197.44 Million
--
pp = percentage points

About Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A

SHG:688212 China Medical Devices
Market Cap
$557.87 Million
CN¥3.81 Billion CNY
Market Cap Rank
#11332 Global
#3165 in China
Share Price
CN¥28.31
Change (1 day)
-2.14%
52-Week Range
CN¥24.71 - CN¥51.41
All Time High
CN¥81.71
About

Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general … Read more